Mikhail Titov

Mikhail Titov

Auto-generated profile, based on publicly available information

Mikhail Titov

Brookhaven National Laboratory

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2021 in IEEE Transactions on Parallel and Distributed Systems
Verified
Journal Article
Closed access
AMAndre Merzky
Andre Merzky
MTMatteo Turilli
Matteo Turilli
MTMikhail Titov
Mikhail Titov
AAAymen Al-Saadi
Aymen Al-Saadi
SJShantenu Jha
Shantenu Jha
Many extreme scale scientific applications have workloads comprised of a large number of individual high-performance tasks. The Pilot abstraction decouples workload specification, resource management, and task execution via job placeholders and late-binding. As such, suitable implementations of the Pilot abstraction can support the collective execution of large number of tasks on supercomputers. We introduce RADICAL-Pilot (RP) as a portable, modular and extensible pilot-enabled runtime system. We describe RP's design, architecture and implementation. We characterize its performance and show its ability to scalably execute workloads comprised of tens of thousands heterogeneous tasks on DOE and NSF leadership-class HPC platforms. Specifically, we investigate RP's weak/strong scaling with CPU/GPU, single/multi core, (non)MPI tasks and Python functions when using most of ORNL Summit and TACC Frontera. RADICAL-Pilot can be used stand-alone, as well as the runtime for third-party workflow systems.

9 August 2021
Verified
Conference Paper
Open access
ASAymen Al Saadi
Aymen Al Saadi
DADario Alfe
Dario Alfe
YBYadu Babuji
Yadu Babuji
ABAgastya Bhati
Agastya Bhati
BBBen Blaiszik
Ben Blaiszik
JYJunqi Yin
Junqi Yin
The drug discovery process currently employed in the pharmaceutical industry typically requires about 10 years and $2–3 billion to deliver one new drug. This is both too expensive and too slow, especially in emergencies like the COVID-19 pandemic. In silico methodologies need to be improved both to select better lead compounds, so as to improve the efficiency of later stages in the drug discovery protocol, and to identify those lead compounds more quickly. No known methodological approach can deliver this combination of higher quality and speed. Here, we describe an Integrated Modeling PipEline for COVID Cure by Assessing Better LEads (IMPECCABLE) that employs multiple methodological innovations to overcome this fundamental limitation. We also describe the computational framework that we have developed to support these innovations at scale, and characterize the performance of this framework in terms of throughput, peak performance, and scientific results. We show that individual workflow components deliver 100 × to 1000 × improvement over traditional methods, and that the integration of methods, supported by scalable infrastructure, speeds up drug discovery by orders of magnitudes. IMPECCABLE has screened ∼ 1011 ligands and has been used to discover a promising drug candidate. These capabilities have been used by the US DOE National Virtual Biotechnology Laboratory and the EU Centre of Excellence in Computational Biomedicine.

5 July 2021
Verified
Conference Paper
Open access
HLHyungro Lee
Hyungro Lee
AMAndre Merzky
Andre Merzky
LTLi Tan
Li Tan
MTMikhail Titov
Mikhail Titov
MTMatteo Turilli
Matteo Turilli
SJShantenu Jha
Shantenu Jha
COVID-19 has claimed more than 2.7 × 106 lives and resulted in over 124 × 106 infections. There is an urgent need to identify drugs that can inhibit SARS-CoV-2. We discuss innovations in computational infrastructure and methods that are accelerating and advancing drug design. Specifically, we describe several methods that integrate artificial intelligence and simulation-based approaches, and the design of computational infrastructure to support these methods at scale. We discuss their implementation, characterize their performance, and highlight science advances that these capabilities have enabled.

18 December 2019 in Journal of Digital Science
Verified
Journal Article
Closed access
ABArtem Balyakin
Artem Balyakin
STSergey Taranenko
Sergey Taranenko
MNMarina Nurbina
Marina Nurbina
MTMikhail Titov
Mikhail Titov
Big Data is supposed to be one of the main traits of new coming digital era. Its technological aspects are usually widely discussed, whereas social peculiarities are mostly neglected. We present main approaches to Big Data, and argue that despite seeming revolutionary technology, Big Data can be treated as a new tool to produce knowledge. That means, it generates the same risks and challenges as other breakthroughs we witnessed previously. To our viewpoint, cultural aspects should be as counted as a main issue in Big Data implementation. Since the inability to control big data through prohibiting some peculiar features it possesses, we argue that one should focus on such practical steps as terminology improvements, and the evaluation of societal outcomes of the new technology.

24 December 2018 in Scientific Visualization
Verified
Journal Article
Closed access
TGT. Galkin
T. Galkin
MGM. Grigoryeva
M. Grigoryeva
AKA. Klimentov
A. Klimentov
TKT. Korchuganova
T. Korchuganova
IMI. Milman
I. Milman
MTM. Titov
M. Titov

12 November 2023
Verified
Conference Paper
Open access
JBJonathan Bader
Jonathan Bader
JBJim Belak
Jim Belak
MBMatthew Bement
Matthew Bement
MBMatthew Berry
Matthew Berry
RCRobert Carson
Robert Carson
AMAnirban Mandal
Anirban Mandal
The annual Workshop on Workflows in Support of Large-Scale Science (WORKS) is a premier venue for the scientific workflow community to present the latest advances in research and development on the many facets of scientific workflows throughout their life-cycle. The Lightning Talks at WORKS focus on describing a novel tool, scientific workflow, or concept, which are work-in-progress and address emerging technologies and frameworks to foster discussion in the community. This paper summarizes the lightning talks at the 2023 edition of WORKS, covering five topics: leveraging large language models to build and execute workflows; developing a common workflow scheduler interface; scaling uncertainty workflow applications on exascale computing systems; evaluating a transcriptomics workflow for cloud vs. HPC systems; and best practices in migrating legacy workflows to workflow management systems.